3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
29
Neoplasms
28
Depression
25
Fatigue
18
Prostatic Neoplasms
12
Anxiety Disorders
12
Pain
8
Lung Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Colonic Neoplasms
6
Vomiting
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Nausea
5
Multiple Myeloma
5
Uterine Cervical Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Head and Neck Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Burkitt Lymphoma
4
Testicular Neoplasms
3
Neuroblastoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Lidocaine
2
Bupivacaine
2
Therapeutics
1
Sodium Chloride
1
Radiofrequency Ablation
1
Musculoskeletal Manipulations
1
Methylprednisolone
1
Injections
1
Decompression
1
Cryosurgery
1
Botulinum Toxins, Type A
1
Anesthetics, Local
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neuroma
×
Therapeutics
×
Clear all
NCT04662320
2024-12-05
PHONES
Checkpoint Surgical Inc.
Phase NA
Active not recruiting
100 enrolled